Hanmi Pharm. Co., Ltd. (KOSE: A128940)
Health Care · Pharmaceuticals · KR
₩480,500.00
-5.04% today · +37.7% 1Y
Hanmi Pharm. Co., Ltd. (KOSE: A128940) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.54B.
Over the last twelve months the share price has gained 37.7%, trading between 302.00K and 647.00K.
Tweenvest scores Hanmi Pharm. Co., Ltd. across four factors: quality 85/100, value 31/100, dividend 6/100. Its strongest factor is quality.
A128940 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.54B
- Revenue (TTM)
- $1.07B
- P/E
- 28.10
- EPS
- 17,098.38
- Dividend yield
- 0.42%
- Beta (5Y)
- 0.53
- 52-week high
- ₩647,000.00
- 52-week low
- ₩302,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 12.69M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Ipca Laboratories LimitedNSEI: IPCALAB | $5.02B | Rs1,915.40 | -1.43% |
| Beijing Tongrentang Co., LtdSHSE: 600085 | $4.97B | CN¥24.28 | +2.27% |
| Definium Therapeutics, Inc.NasdaqGS: DFTX | $4.96B | $35.04 | -5.04% |
| Humanwell Healthcare (Group) Co.,Ltd.SHSE: 600079 | $4.69B | CN¥19.23 | +0.31% |
| Sumitomo Pharma Co., Ltd.TSE: 4506 | $4.51B | ¥1,591.50 | -1.36% |
| Hikma Pharmaceuticals PLCLSE: HIK | $4.46B | £16.29 | +1.05% |
| Dong-E-E-Jiao Co., Ltd.SZSE: 000423 | $4.45B | CN¥46.68 | +0.56% |
| GlaxoSmithKline Pharmaceuticals LimitedBSE: 500660 | $4.45B | Rs2,539.80 | -8.46% |
Figures last refreshed Oct 11, 2026.